Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Ways to maintain budget motivation during adjustments helps you stay committed as you recalibrate. Discover practical tips and stay on course.
21,579 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Berkshire Hathaway ramps up buybacks and sits on a large cash cushion, while Pershing Square slips 16% year-to-date a...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
A Reuters briefing this week reignited the debate over Banksy’s anonymity and its effect on art values, prompting a r...
Momentum can flip quickly in growth stocks, but today some names look cheap for the upside potential. This guide high...
Ethereum sits at a pivotal juncture around $2,160, with on-chain activity signaling caution and institutional demand ...
BMO Capital Markets cuts Lithium Americas' price target to $4.50, citing 15% capex inflation at Thacker Pass and ongo...
Major indices surge as news of a potential Iran peace framework reduces geopolitical risk. Oil slides below $100, eas...
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
The Reserve Bank of Australia quantifies AUD 24 billion in annual gains from tokenizing wholesale assets, as Project ...
A new AP-NORC poll reveals a sharp split between women and men on wage opportunities, signaling persistent pay gaps a...